Literature DB >> 16376281

Levetiracetam in a neonate with malignant migrating partial seizures.

Ghassan Hmaimess1, Hazim Kadhim, Marie-Cécile Nassogne, Christine Bonnier, Kenou van Rijckevorsel.   

Abstract

This report describes the first neonatal case of "malignant migrating partial seizures in infancy" with a positive therapeutic response to levetiracetam. This patient is the youngest reported infant with this rare syndrome, and the report provides the first documentation on levetiracetam treatment in a neonatal patient. Treatment with levetiracetam improved both ictal and interictal status. This observation also highlights the need to consider and include malignant migrating partial seizures in the differential diagnosis of early neonatal seizure disorders, even during the first hours of life.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16376281     DOI: 10.1016/j.pediatrneurol.2005.06.011

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  14 in total

1.  Levetiracetam for treatment of neonatal seizures.

Authors:  Nicholas S Abend; Ana M Gutierrez-Colina; Heather M Monk; Dennis J Dlugos; Robert R Clancy
Journal:  J Child Neurol       Date:  2011-01-13       Impact factor: 1.987

Review 2.  Levetiracetam in neonatal seizures: a review.

Authors:  Allison L Mruk; Karen L Garlitz; Noelle R Leung
Journal:  J Pediatr Pharmacol Ther       Date:  2015 Mar-Apr

Review 3.  Neonatal seizures: an update on mechanisms and management.

Authors:  Frances E Jensen
Journal:  Clin Perinatol       Date:  2009-12       Impact factor: 3.430

4.  Migrating partial seizures of infancy: expansion of the electroclinical, radiological and pathological disease spectrum.

Authors:  Amy McTague; Richard Appleton; Shivaram Avula; J Helen Cross; Mary D King; Thomas S Jacques; Sanjay Bhate; Anthony Cronin; Andrew Curran; Archana Desurkar; Michael A Farrell; Elaine Hughes; Rosalind Jefferson; Karine Lascelles; John Livingston; Esther Meyer; Ailsa McLellan; Annapurna Poduri; Ingrid E Scheffer; Stefan Spinty; Manju A Kurian; Rachel Kneen
Journal:  Brain       Date:  2013-04-18       Impact factor: 13.501

5.  Neonatal seizures.

Authors:  Hannah C Glass; Joseph E Sullivan
Journal:  Curr Treat Options Neurol       Date:  2009-11       Impact factor: 3.598

6.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy.

Authors:  Giulia Barcia; Matthew R Fleming; Aline Deligniere; Valeswara-Rao Gazula; Maile R Brown; Maeva Langouet; Haijun Chen; Jack Kronengold; Avinash Abhyankar; Roberta Cilio; Patrick Nitschke; Anna Kaminska; Nathalie Boddaert; Jean-Laurent Casanova; Isabelle Desguerre; Arnold Munnich; Olivier Dulac; Leonard K Kaczmarek; Laurence Colleaux; Rima Nabbout
Journal:  Nat Genet       Date:  2012-10-21       Impact factor: 38.330

7.  Efficacy of levetiracetam as first-line therapy for neonatal clinical seizures and neurodevelopmental outcome at 12 months of age.

Authors:  Seda Kanmaz; Özge Altun Köroğlu; Demet Terek; Hepsen Mine Serin; Erdem Simsek; İpek Dokurel Cetin; Sanem Yilmaz; Mehmet Yalaz; Gul Aktan; Mete Akisu; Nilgun Kultursay; Sarenur Gokben; Hasan Tekgul
Journal:  Acta Neurol Belg       Date:  2020-05-18       Impact factor: 2.396

8.  Update on rufinamide in childhood epilepsy.

Authors:  Giangennaro Coppola
Journal:  Neuropsychiatr Dis Treat       Date:  2011-07-05       Impact factor: 2.570

Review 9.  Electroencephalogram of age-dependent epileptic encephalopathies in infancy and early childhood.

Authors:  Lily C Wong-Kisiel; Katherine Nickels
Journal:  Epilepsy Res Treat       Date:  2013-08-19

10.  Efficacy and tolerability of intravenous levetiracetam in childrens.

Authors:  Jose Aceves; Owais Khan; Diana Mungall; Ekokobe Fonkem; Chanin Wright; Andrea Wenner; Batool Kirmani
Journal:  Front Neurol       Date:  2013-08-14       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.